Overview
LMAT market data
Price History
LMAT price chart
Valuation & Profitability
- P/E (TTM)
- 28.60 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.52 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.46 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.2% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 25.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $78.65 – $118.01 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.9B · P/B 4.68 · P/S 7.16.
Company News
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94Benzinga · Aug 5, 2026, 3:04 PM
LeMaitre Vascular shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 GAAP EPS and FY2026 sales guidance.Benzinga · Aug 5, 2026, 11:41 AM
8-K filing — LEMAITRE VASCULAR INC (LMAT)SEC EDGAR · Aug 4, 2026, 8:39 PM
LeMaitre Vascular Sees Q4 GAAP EPS $0.75-$0.81 vs $0.78 Est; Sees Sales $71.100M-$73.100M vs $72.745M EstBenzinga · Aug 4, 2026, 8:28 PM
LeMaitre Vascular Sees Q3 GAAP EPS $0.66-$0.71 vs $0.73 Est; Sees Sales $66.300M-$68.300M vs $69.246M EstBenzinga · Aug 4, 2026, 8:25 PM
LeMaitre Vascular Lowers FY2026 GAAP EPS Guidance from $2.93-$3.08 to $2.84-$2.94 vs $2.97 Est; Lowers FY2026 Sales Guidance from $277.000M-$283.000M to $274.300M-$278.300M vs $279.948M EstBenzinga · Aug 4, 2026, 8:25 PM
LeMaitre Vascular Q2 EPS $0.74 Misses $0.79 Estimate, Sales $70.382M Miss $70.973M EstimateBenzinga · Aug 4, 2026, 8:06 PM